General Anesthesia Practice Questions

Q: What is the skeletal muscle relaxant of choice in patients with liver and renal disease?

Atracurium. **Explanation:** The muscle relaxant of choice in patients with liver and renal failure is **Atracurium** (or its isomer, Cisatracurium). **Why Atracurium is the Correct Answer:** Atracurium is unique because its metabolism is independent of organ function. It undergoes **Hofmann Elimination** (a spontaneous non-enzymatic degradation at physiological pH and temperature) and **Ester Hydrolysis** (by non-specific plasma esterases). Since it does not rely on the liver for metabolism or the kidneys for excretion, its duration of action remains predictable even in end-organ failure. **Analysis of Incorrect Options:** * **Mivacurium:** While it is metabolized by plasma cholinesterase, its duration can be significantly prolonged in patients with liver disease due to reduced synthesis of the cholinesterase enzyme. * **Gallamine:** This is a long-acting relaxant that is excreted almost entirely (95-100%) unchanged by the **kidneys**. It is strictly contraindicated in renal failure as it leads to profound cumulative toxicity. * **Vecuronium:** It is primarily metabolized by the liver and excreted via bile (40-50%) and urine. Its action is prolonged in patients with hepatic dysfunction and, to a lesser extent, renal failure. **High-Yield NEET-PG Pearls:** * **Cisatracurium:** It is more potent than atracurium and is preferred because it produces less **laudanosine** (a metabolite that can cause seizures) and does not cause histamine release. * **Drug of Choice for RSI in Renal Failure:** Rocuronium (if Succinylcholine is contraindicated due to hyperkalemia). * **Hofmann Elimination** is faster in states of **hyperthermia and alkalosis**, and slower in hypothermia and acidosis.

Q: Which of the following inhalational agents is contraindicated in renal disease?

Methoxyflurane. **Explanation:** The correct answer is **Methoxyflurane**. **1. Why Methoxyflurane is correct:** Methoxyflurane is highly lipid-soluble and undergoes extensive hepatic metabolism (up to 50–70%). This metabolism releases high concentrations of **inorganic fluoride ions (F⁻)**. Fluoride ions are nephrotoxic; they interfere with the concentrating mechanism of the distal convoluted tubules and collecting ducts, leading to **Vasopressin-resistant high-output renal failure** (polyuric renal failure). Due to this high risk of nephrotoxicity, it is no longer used for general anesthesia. **2. Why the other options are incorrect:** * **Sevoflurane:** While Sevoflurane also releases fluoride ions and can produce **Compound A** (a vinyl ether) when reacting with soda lime, clinical studies have shown it does not cause significant renal injury in humans under standard conditions. It is frequently used in clinical practice. * **Desflurane & Isoflurane:** These agents undergo minimal metabolism (0.02% and 0.2% respectively). They release negligible amounts of fluoride ions and are considered safe for patients with renal impairment. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolism Gradient:** Methoxyflurane (50%) > Halothane (20%) > Sevoflurane (2%) > Enflurane (2%) > Isoflurane (0.2%) > Desflurane (0.02%). * **Compound A:** Associated with Sevoflurane; produced in CO₂ absorbers (especially with low-flow anesthesia and Baralyme). * **Agent of Choice in Renal Failure:** **Isoflurane** or **Desflurane** are generally preferred due to minimal metabolism. * **Current Use:** Methoxyflurane is now only used in low doses as a self-administered analgesic for trauma/emergency procedures (the "green whistle").

Q: Which of the following does not have analgesic properties?

Halothane. **Explanation:** The core concept in general anesthesia is the "triad of anesthesia," which includes **amnesia (unconsciousness), analgesia (pain relief), and muscle relaxation.** Not all anesthetic agents provide all three components. **Why Halothane is the correct answer:** Halothane is a potent inhalational anesthetic known for its smooth induction and bronchodilatory properties. However, it is a **poor analgesic**. At sub-anesthetic concentrations, it may even cause "hyperalgesia" (increased sensitivity to pain). Therefore, it must be supplemented with analgesic agents (like opioids or nitrous oxide) to ensure patient comfort during and after surgery. **Analysis of Incorrect Options:** * **Ether:** Historically significant, ether is a "complete anesthetic." It provides excellent analgesia, amnesia, and muscle relaxation. * **Ketamine:** A phencyclidine derivative that produces "dissociative anesthesia." It is a **potent analgesic** even at sub-anesthetic doses, acting primarily via NMDA receptor antagonism. * **Morphine:** The gold standard opioid agonist. Its primary clinical use is for profound systemic analgesia. **High-Yield Clinical Pearls for NEET-PG:** * **Inhalational Agents & Analgesia:** Most volatile liquids (Halothane, Sevoflurane, Isoflurane) are poor analgesics. **Nitrous Oxide ($N_2O$)** is the notable exception, providing significant analgesia. * **Halothane Side Effects:** Watch for "Halothane Hepatitis" and its ability to sensitize the myocardium to catecholamines (leading to arrhythmias). * **Ketamine:** The drug of choice for induction in patients with asthma or hypovolemic shock, but contraindicated in head injuries due to increased intracranial pressure (ICP).

Q: Which of the following statements is NOT true regarding non-depolarizing muscle relaxants?

Metabolized by pseudocholinesterase.. ### Explanation **Correct Answer: C. Metabolized by pseudocholinesterase.** **Why Option C is NOT true:** Non-depolarizing muscle relaxants (NDMRs) like Atracurium, Vecuronium, and Rocuronium are metabolized through various pathways such as **Hofmann elimination** (Atracurium/Cisatracurium) or **hepatic/renal excretion**. **Pseudocholinesterase** (butyrylcholinesterase) is specifically responsible for the metabolism of **Succinylcholine** (the only depolarizing muscle relaxant) and ester-type local anesthetics. NDMRs are not metabolized by this enzyme. **Analysis of Other Options:** * **Option A (Magnesium):** Magnesium inhibits the pre-synaptic release of Acetylcholine (ACh) and decreases post-junctional sensitivity. Therefore, it **potentiates** (predisposes to) the block of both depolarizing and non-depolarizing agents. * **Option B (Calcium):** Calcium is essential for the release of ACh from the motor nerve terminal. High levels of calcium can increase ACh release, thereby **antagonizing** the competitive block produced by NDMRs. * **Option D (Mechanism):** NDMRs act as **competitive antagonists** at the nicotinic ACh receptors (Nm) of the motor endplate. They bind to the receptor but do not trigger an action potential, preventing ACh from binding. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mivacurium** is the only NDMR that is actually metabolized by pseudocholinesterase (making it the shortest-acting NDMR). 2. **Hofmann Elimination:** A non-enzymatic, spontaneous degradation dependent on pH and temperature (seen with Atracurium and Cisatracurium). It is the method of choice in patients with **liver or kidney failure**. 3. **Sugammadex:** A specific reversal agent for Rocuronium and Vecuronium (aminosteroid NDMRs). 4. **Electrolyte Interactions:** Hypokalemia, hypocalcemia, and hypermagnesemia all **potentiate** the action of NDMRs.

Q: Which of the following anesthetic agents is contraindicated in patients with hypertension?

Ketamine. **Explanation:** **Ketamine (Option A)** is the correct answer because it is a **sympathomimetic** anesthetic agent. Unlike most induction agents that cause respiratory and cardiovascular depression, ketamine stimulates the sympathetic nervous system. It inhibits the reuptake of catecholamines (norepinephrine), leading to a significant **increase in heart rate, cardiac output, and arterial blood pressure.** Consequently, it is strictly contraindicated in patients with hypertension, ischemic heart disease, or a history of stroke, as the sudden rise in blood pressure can trigger myocardial infarction or intracranial hemorrhage. **Why the other options are incorrect:** * **Propofol (Option B):** Known for causing significant vasodilation and myocardial depression, leading to a **decrease in blood pressure**. It is often used cautiously in hypertensive patients to blunt the intubation response. * **Etomidate (Option C):** Renowned for its **hemodynamic stability**. It causes minimal changes in heart rate and blood pressure, making it the drug of choice for patients with compromised cardiac function, though not contraindicated in hypertension. * **Diazepam (Option D):** A benzodiazepine that typically causes mild systemic vasodilation and a slight decrease in blood pressure; it does not cause hypertension. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Ketamine is the induction agent of choice for **hypovolemic shock** and **bronchial asthma** (due to its bronchodilatory properties). * **Avoid in:** Hypertension, Raised Intraocular Pressure (IOP), and Raised Intracranial Pressure (ICP). * **Dissociative Anesthesia:** Ketamine produces a state where the patient appears awake but is unconscious and amnesic, characterized by "eyes wide open" and a slow nystagmic gaze.

Q: What is the proposed mechanism of the dissociative anesthesia effect of ketamine?

Both. **Explanation:** Ketamine is a unique anesthetic agent that produces a state known as **"Dissociative Anesthesia."** This state is characterized by a functional and electrophysiological dissociation between the thalamocortical system and the limbic system. 1. **Why "Both" is correct:** * **Inhibition of the Thalamocortical Pathway:** Ketamine acts as a non-competitive antagonist at the **NMDA receptors**. By inhibiting this pathway, it prevents the transmission of sensory impulses (pain, touch, sound) from the periphery to the cerebral cortex. This results in profound analgesia and amnesia. * **Stimulation of the Limbic System:** While the cortex is depressed, the limbic system (involved in emotions and memory) remains active or even stimulated. This "dissociation" explains why patients may appear awake (eyes open, slow nystagmic gaze) but are unable to process or respond to sensory input. 2. **Analysis of Options:** * **Option A & B:** These are individual components of the mechanism. Selecting only one would be incomplete, as the "dissociative" effect specifically requires the simultaneous depression of the sensory relay (thalamocortical) and the relative excitation of the emotional center (limbic). **High-Yield Clinical Pearls for NEET-PG:** * **Emergence Delirium:** The stimulation of the limbic system is responsible for "emergence reactions" (hallucinations/vivid dreams). This can be prevented by pre-treating with **Benzodiazepines** (Midazolam). * **Sympathomimetic Effect:** Unlike most induction agents, Ketamine increases HR, BP, and CO, making it the **drug of choice for hypovolemic shock**. * **Respiratory Effects:** It is a potent **bronchodilator** (ideal for asthmatics) and uniquely preserves protective airway reflexes and respiratory drive. * **Contraindication:** It increases Intraocular Pressure (IOP) and Intracranial Pressure (ICP), so it should be avoided in head injuries and glaucoma.

Q: Which anesthetic gas is contraindicated in the presence of pneumothorax?

Nitrous oxide. **Explanation** The correct answer is **Nitrous oxide ($N_2O$)**. **Mechanism of Action** The contraindication of $N_2O$ in pneumothorax is based on the **Second Gas Effect** and the difference in blood solubility between $N_2O$ and Nitrogen ($N_2$). * $N_2O$ is **34 times more soluble** in blood than Nitrogen. * When a patient has a pneumothorax, the air pocket contains mostly Nitrogen. When $N_2O$ is administered, it diffuses from the blood into the air-filled cavity much faster than Nitrogen can diffuse out. * This leads to a rapid increase in the **volume** (if the cavity is compliant) or **pressure** (if the cavity is non-compliant) of the space. In a pneumothorax, this can rapidly expand the collapse or convert a simple pneumothorax into a life-threatening **tension pneumothorax**. **Analysis of Incorrect Options** * **Halothane and Isoflurane:** These are volatile halogenated ethers/alkanes. While they affect respiratory drive, they do not significantly diffuse into closed gas spaces to cause expansion. * **Chloroform:** An obsolete anesthetic agent; like other volatile liquids, it does not share the specific solubility characteristics of $N_2O$ that lead to gas space expansion. **High-Yield NEET-PG Pearls** * **Other Contraindications for $N_2O$:** Intestinal obstruction, air embolism, middle ear surgeries (tympanoplasty), intraocular gas bubbles (sulfur hexafluoride), and Vitamin B12 deficiency (due to methionine synthase inhibition). * **Expansion Rule:** $N_2O$ at 75% concentration can double the volume of a pneumothorax in just 10 minutes. * **Diffusion Hypoxia:** Always administer 100% $O_2$ for 5–10 minutes after disconnecting $N_2O$ to prevent the rapid washout of $N_2O$ from diluting alveolar oxygen.

Question 1

A patient undergoing surgical procedure under general anesthesia suddenly develops tachycardia, hypertension, sweating, and tachypnea. What is the best immediate step to manage the situation?

Accepted Answer

Deepen the plane of anesthesia

Answer

Administer an IV beta-blocker

Answer

Abandon the surgery

Answer

No intervention is required

Question 2

Regarding ketamine, all the following statements are true EXCEPT:

Accepted Answer

It is contraindicated in shock.

Answer

Ketamine acts on NMDA receptors in the brain.

Answer

It is an indirectly acting sympathomimetic agent.

Answer

It is an agent of choice in asthma patients.

Question 3

What is the skeletal muscle relaxant of choice in patients with liver and renal disease?

Accepted Answer

Atracurium

Answer

Mivacurium

Answer

Gallamine

Answer

Vecuronium

Question 4

Succinylcholine causes hyperkalemia in patients with which of the following conditions?

Accepted Answer

All of the above

Answer

Burns

Answer

Severe infection

Answer

High velocity trauma

Question 5

Which of the following inhalational agents is contraindicated in renal disease?

Accepted Answer

Methoxyflurane

Answer

Sevoflurane

Answer

Desflurane

Answer

Isoflurane

Question 6

Which of the following does not have analgesic properties?

Accepted Answer

Halothane

Answer

Ether

Answer

Ketamine

Answer

Morphine

Question 7

Which of the following statements is NOT true regarding non-depolarizing muscle relaxants?

Accepted Answer

Metabolized by pseudocholinesterase.

Answer

Magnesium predisposes to the neuromuscular block.

Answer

Calcium antagonizes the neuromuscular block.

Answer

Acts as a competitive inhibitor of acetylcholine.

Question 8

Which of the following anesthetic agents is contraindicated in patients with hypertension?

Accepted Answer

Ketamine

Answer

Propofol

Answer

Etomidate

Answer

Diazepam

Question 9

What is the proposed mechanism of the dissociative anesthesia effect of ketamine?

Accepted Answer

Both

Answer

Inhibition of the thalamocortical pathway

Answer

Stimulation of the limbic system

Answer

None

Question 10

Which anesthetic gas is contraindicated in the presence of pneumothorax?

Accepted Answer

Nitrous oxide

Answer

Halothane

Answer

Isoflurane

Answer

Chloroform

General Anesthesia — MCQs

General Anesthesia — MCQs

On this page

Practice by Chapter

Want unlimited practice?